A 42-year-old woman with right breast cancer cT4dN2M0 HR +, HER2 +, undergoes mastectomy with axillary lymphadenectomy after neoadjuvant chemotherapy. During adjuvant treatment with trastuzumab and hormone therapy, the patient develops multiple symptomatic encephalic metastases. She undergoes panencephalic radiotherapy and begins chemotherapy with capecitabine and lapatinib. After three months of well tolerated therapy, an important volumetric response of encephalic metastases is observed, with regression of neurological symptoms.

Galanti D., Vaccaro G., Cipolla C., Graceffa G., & Valerio M.R. (2020). Lapatinib activity in a patient with encephalic metastases from trastuzumab-resistant her-2 positive breast cancer. ACTA MEDICA MEDITERRANEA, 36(5), 2985-2987 [10.19193/0393-6384_2020_5_458].

Lapatinib activity in a patient with encephalic metastases from trastuzumab-resistant her-2 positive breast cancer

Vaccaro G.;Cipolla C.;Graceffa G.;Valerio M. R.
2020

Abstract

A 42-year-old woman with right breast cancer cT4dN2M0 HR +, HER2 +, undergoes mastectomy with axillary lymphadenectomy after neoadjuvant chemotherapy. During adjuvant treatment with trastuzumab and hormone therapy, the patient develops multiple symptomatic encephalic metastases. She undergoes panencephalic radiotherapy and begins chemotherapy with capecitabine and lapatinib. After three months of well tolerated therapy, an important volumetric response of encephalic metastases is observed, with regression of neurological symptoms.
Galanti D., Vaccaro G., Cipolla C., Graceffa G., & Valerio M.R. (2020). Lapatinib activity in a patient with encephalic metastases from trastuzumab-resistant her-2 positive breast cancer. ACTA MEDICA MEDITERRANEA, 36(5), 2985-2987 [10.19193/0393-6384_2020_5_458].
File in questo prodotto:
File Dimensione Formato  
Acta Med Medit 2020 - LAPATINIB ACTIVITY.pdf

Solo gestori archvio

Tipologia: Versione Editoriale
Dimensione 208.68 kB
Formato Adobe PDF
208.68 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10447/435424
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact